INTRODUCTION
In 2013, there were a total of 382 million patients with diabetes mellitus (DM) worldwide. [1] Two years later, this number had increased to 415 million patients. [2] In the Middle East and North Africa, there were 35.4 million (9.1%) DM patients aged 20-79 years. Of this population, approximately 3.49 million were located in Saudi Arabia. Therefore, the prevalence of diabetes in this country is (17.6%) one of the highest worldwide. [2] As a result, DM one of the largest health issues in Saudi Arabia, and it is associated with major social and economic burdens.
Anxiety is one of the most prevalent psychiatric problems, particularly among females and low-socioeconomic individuals. [3] The lifetime rate of anxiety disorders in the United States was 28.8% in a recent study. [4] Untreated anxiety can lead to other psychiatric conditions such as depression, substance abuse (including nicotine and alcohol), and even suicide. [5] [6] [7] Anxiety also increases the risk of heart diseases, obesity, and irritable bowel syndrome. [8] [9] [10] A systemic review found a strong association between anxiety and depression and heart diseases, stroke, DM, asthma, cancer, arthritis, and osteoporosis, which highlights the evidence of increased morbidity and mortality associated with anxiety. [11] Diabetes is a chronic disease that affects people physically and mentally. It requires strict management and the engagement of both a health-care provider and a patient; poor control and compliance due to anxiety can lead to an increased risk of complications. [12] Studies have shown that in people with type 2 diabetes (T2D) stress has the ability to worsen the condition directly by causing hyperglycemia and indirectly by reducing compliance. [13] Anxiety disorders are believed to be more prevalent in people who have chronic illnesses compared with healthy people. [11] A study carried out in South Africa with a total of 401 participants revealed that 32% of people had an anxiety disorder. [14] A small study of patients with T2D showed, using the Generalized Anxiety Disorder-7 (GAD-7) questionnaire, that 34% of individuals screened positive for anxiety and that the majority of participants had mild anxiety. [15] In light of these findings, we conducted this study to explore the prevalence of anxiety in T2D Saudi patients and also to examine the possible risk factors associated with such a diagnosis such as gender, age, financial status, educational level, exercise status, and smoking status. We also examined the impact of anxiety on glycemic control, measured cardiovascular markers, and T2D-related complications.
METHODS
We conducted this cross-sectional study from October 2015 to July 2016 in Taif City, Saudi Arabia. T2D patients above the age of 18 years who had a routine follow-up visit were allowed to participate. If these individuals verbally consented to participate, they were included. We excluded patients with T1D and individuals with known psychiatric illnesses, untreated hypothyroidism, or gestational diabetes. Researchers interviewed the participants and inquired about personal data, current DM management, comorbidities, T2D-related complications, and social habits. Anthropometric measurements were taken, and the most recent laboratory test results were obtained from participants' files using universal medical record numbers. We considered those who reported monthly incomes <$1335 USD as being low income.
For anxiety screening, we used the GAD-7 scale, which has 89% sensitivity and 82% specificity for a GAD diagnosis. [16] [17] [18] This scale consists of seven statements regarding anxiety symptoms; each statement can be scored from 0 to 3 according to the frequency of occurrence within the previous 2 weeks. As a result, the total possible score on the GAD-7 ranges from 0 to 21. Scores of 5, 10, and 15 represent cutoff points for mild, moderate, and severe anxiety, respectively.
The data were analyzed using Statistical Package for the Social Sciences (SPSS) version 20 IBM based on (Armonk, New York, United States). The Chi-squared test was used to study the relationship between variables, and the t-test was used to compare between means. Two-tailed partial correlation was conducted between GAD-7 score and both glycemic control and T2D-related complications.
RESULTS
A total of 231 patients with T2D participated in the study. The cohort had a mean age of 59.7 ± 11.0 years. The majority of them were male with long-standing diabetes; their mean body mass index (BMI) was in the obese range. The patients' mean waist circumference was 110.1 ± 13.6 cm, and their mean systolic blood pressure and diastolic blood pressure were within the normal range of T2D patients.
The majority of the patients were married, and more than half of them were characterized as low income. Only 12.1% of the patients had a bachelor's degree or higher. Approximately half of our patients (42.9%) lived a sedentary lifestyle; only one-fifth of the patients exercised >150 min/week. About 13% of the patients were active smokers.
The most prevalent complication was neuropathy followed by retinopathy, hypoglycemia, and renal failure. More than half of the patients were on a combination of oral hypoglycemic agents and insulin. The most commonly used oral hypoglycemic agent was metformin, and 75.3% of the patients were taking a statin.
The laboratory data revealed uncontrolled hemoglobin A1c (HbA1c), a mean total cholesterol of 4.6 ± 2.6 mmol/L, a mean low-density lipoprotein of 2.7 ± 0.9 mmol/L, a mean high-density lipoprotein of 1.0 ± 0.3 mmol/L, mean triglycerides of 1.7 ± 0.9 mmol/L, and a mean albumin-creatinine ratio of 25.5 ± 112.1 mg/mmol [ Table 1 ].
About 45% of our sample was found to be anxious. Compared to individuals who were anxious, people without anxiety were more likely to be low income (P = 0.045).
Individuals who are anxious were insignificantly more likely to be younger females and have higher levels of education [ Table 2 ].
A partial correlation adjusting for age, gender, duration of T2D, income, educational level, BMI, waist circumference, and medication showed a significant negative correlation between GAD-7 score and retinopathy (r = −0.181; P = 0.007), a significant negative correlation between GAD-7 score and neuropathy (r = −0.145; P = 0.031), and a nonsignificant positive correlation between GAD-7 score and HbA1c (r = 0.016; P = 0.811).
DISCUSSION
Numerous studies have noted a high prevalence of anxiety among T2D patients. [15, [19] [20] [21] [22] [23] [24] [25] [26] [27] [28] [29] Anxiety has also been linked to increased mortality in T2D patients. [30] In our study, the prevalence of anxiety was 45.45%; another study in Saudi Arabia demonstrated a prevalence of 38.4%. [19] We note that the prevalence of T2D varies across the globe and even within the same country in different studies. [15, 22, 25, 26] However, the highest prevalence has been noted in Iran and Guiana. [20, 28] These fluctuations may be due to various factors such as the use of different screening tools, culture and/or ethnicity. Other factors may also play a role in the observed high prevalence of anxiety in Saudi Arabia such as low levels of health education and the high prevalence of T2D, which may lead to incorrect perceptions of the disease because its complications are common.
There is a wide discrepancy in the results concerning associated sociodemographic factors. The only significant correlation we found was the association between low income and a prevalence of anxiety. However, other studies have suggested contradictory results for unknown reasons. [23, 26, 28, 29] While most other studies have suggested a high prevalence of anxiety among female participants, [19] [20] [21] [22] [23] 27, 29] a few other investigations, including our own, found no link between gender and anxiety. [15, 25, 26] Older individuals exhibited a higher prevalence of anxiety in some of the studies we reviewed. [21, 22, 25] Other investigations failed to note an association between age and anxiety; [15, 26] younger participants were more susceptible to anxiety in a couple of other studies. [20, 23] We also did not find an association between age and anxiety. There was no association among the duration of T2D, marital status, and anxiety; this finding is in agreement with almost all of the studies we reviewed. [15, 20, 21, 23, [25] [26] [27] 29] Neither BMI nor HbA1c influenced the prevalence of anxiety in our results. However, the data we reviewed were scarce, and all of them were consistent with our findings [19, 22, 26, 29] except for two studies from Tunisia and Guinea. These studies both found an association between anxiety and elevated HbA1c. [27, 28] Rajput et al. found that insulin use was a significant predictor of anxiety. [22] Our study, among others, showed no such association. [20, 23, 26, 29] Furthermore, we noted that smoking and physical activity were not associated with anxiety, which has been suggested by other investigations as well. [19, 26, 29] After adjusting for multiple variables, we found a negative correlation between anxiety and both retinopathy and neuropathy. This finding can be explained by viewing anxiety as a motivation for patients to be alert to new symptoms and for them to visit their health-care provider regularly. We note that high-quality health care is available and free in Taif City, Saudi Arabia. Naicker et al. found that anxious women were more likely to avoid high-fat food and to consume more vegetables; they provided a similar explanation. [31] However, several studies found an association between anxiety and retinopathy. [22, 27] Others found no association between T2D complications and anxiety. [15, 26, 29] 
CONCLUSION
Anxiety was strongly prevalent among the screened T2D patients. Although the anxiety diagnosis did not correlate with worse glycemic control or cardiovascular markers, it was negatively associated with T2D-related microvascular complications.
